Cargando…
Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease
OBJECTIVE: To determine whether there is an association between serum ischemia-modified albumin and the risk factor profile in type 2 diabetic patients with peripheral arterial disease and to identify the risk markers for peripheral arterial disease. METHODS: Participants included 290 patients (35.2...
Autores principales: | Shao-gang, WEI, Chun-ling, HONG, Bing, YU, Wei-nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180151/ https://www.ncbi.nlm.nih.gov/pubmed/22012037 http://dx.doi.org/10.1590/S1807-59322011001000003 |
Ejemplares similares
-
Evaluation of Ischemia-Modified Albumin and C-Reactive Protein in Type 2 Diabetics With and Without Ketosis
por: Ma, Shao-gang, et al.
Publicado: (2012) -
Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels
por: Yang, Liu-Xue, et al.
Publicado: (2013) -
The Role of Ischemia-modified Albumin and Ischemia-Modified Albumin to Albumin Ratios in Patients with Alopecia Areata
por: Tanacan, Efsun, et al.
Publicado: (2023) -
Ischemia-Modified albumin level in type 2 diabetes mellitus—Preliminary report
por: Piwowar, Agnieszka, et al.
Publicado: (2008) -
Ischemia-Modified Albumin: Origins and Clinical Implications
por: Shevtsova, Alla, et al.
Publicado: (2021)